Entinostat (SNDX-275) for the treatment of non-small cell lung cancer Article

Ruiz, Rossana, Raez, Luis E, Rolfo, Christian. (2015). Entinostat (SNDX-275) for the treatment of non-small cell lung cancer . EXPERT OPINION ON INVESTIGATIONAL DRUGS, 24(8), 1101-1109. 10.1517/13543784.2015.1056779

International Collaboration

cited authors

  • Ruiz, Rossana; Raez, Luis E; Rolfo, Christian

sustainable development goals

authors

publication date

  • August 1, 2015

keywords

  • CHEMOTHERAPY
  • DNA METHYLATION
  • GROWTH
  • HISTONE DEACETYLASE INHIBITOR
  • Life Sciences & Biomedicine
  • MS-275
  • PHASE-I
  • Pharmacology & Pharmacy
  • REFRACTORY SOLID TUMORS
  • SUPPORTIVE CARE
  • Science & Technology
  • TRIAL
  • VIVO ANTITUMOR-ACTIVITY
  • entinostat
  • epigenetics
  • histone deacetylase
  • non-small cell lung cancer

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 1101

end page

  • 1109

volume

  • 24

issue

  • 8